Skip to main content
Log in

Cardiac surgery in a patient with essential thrombocythemia: a case report

  • Case report
  • Published:
Netherlands Heart Journal Aims and scope Submit manuscript

Abstract

Patients with essential thrombocythemia (ET) are at increased risk of developing arterial thrombosis. We report a case of a 36-year-man with unstable angina in the presence of occlusion of two coronary arteries with insufficient collateral perfusion. We also found essential thrombocythemia in this patient. The patient underwent coronary artery bypass grafting (CABG). Ten days before surgery, the aspirin was replaced by a prophylactic dose of low-molecular-weight heparin. Postoperative follow-up was complicated by pulmonary embolisms and a cardiac tamponade. We conclude that ET is a risk factor for coronary heart disease that should be treated with aspirin. If a patient needs CABG, aspirin should be continued because of the high risk of thromboembolic events in the high-risk ET patients. (Neth Heart J 2010;18:378-80.)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Schafer AI. Thrombocytosis. N Engl J Med. 2004;350:1211-9.

  2. Hehlmann R, Jahn M, Baumann B, Köpcke W. Essential thrombocythemia: clinical characteristics and course of 61 cases. Cancer. 1988; 61:2487-96.

    Google Scholar 

  3. Tefferi A, Fonseca R, Pereira D, Hoagland H. A long-term retrospective study of young women with essential thrombocythemia. Mayo Clin Proc. 2001;76:22.

    Google Scholar 

  4. Watson KV, Key N. Vascular complications of essential thrombocythaemia: A link to cardiovascular risk factors. Br J Haematol. 1993;83:198.

    Google Scholar 

  5. Ruggeri M, Tosetto A, Rodeghiero F, Finazzi G, Barbui T. The management of ‘low risk’ and ‘intermediate risk’ patients with primary thrombocythemia. Br J Haematol. 1999;106:834.

    Google Scholar 

  6. Harrison CN, Campbell PJ, Buck G, Wheatley K, East CL, Bareford D, et al. Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. N Engl J Med 2005;353:33-45.

    Google Scholar 

  7. Ruggeri M, Rodeghiero F, Tosetto A, Castaman G, Scognamiglio F, Finazzi G, et al.; for the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Chronic Myeloproliferative Diseases Working Party. Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective survey. Blood. 2008;111:666-71.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. E. Schölzel.

Additional information

B.E. Schölzel Department of Cardiology, St. Antonius Hospital, PO Box 2500, 3430 EM Nieuwegein, the Netherlands

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schölzel, B.E., Endeman, H., Dewilde, W. et al. Cardiac surgery in a patient with essential thrombocythemia: a case report. NHJL 18, 378–380 (2010). https://doi.org/10.1007/BF03091797

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03091797

Navigation